Applied Capital LLC’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Hold
5,466
0.17% 80
2026
Q1
$474K Sell
5,466
-100
-2% -$9.58K 0.22% 77
2025
Q4
$535K Buy
5,566
+21
+0.4% +$2.04K 0.32% 72
2025
Q3
$528K Sell
5,545
-250
-4% -$23K 0.33% 67
2025
Q2
$505K Hold
5,795
0.37% 69
2025
Q1
$521K Sell
5,795
-120
-2% -$10.7K 0.41% 66
2024
Q4
$472K Sell
5,915
-250
-4% -$21.6K 0.37% 67
2024
Q3
$555K Sell
6,165
-197
-3% -$16.6K 0.43% 64
2024
Q2
$501K Sell
6,362
-60
-0.9% -$4.92K 0.44% 62
2024
Q1
$560K Hold
6,422
0.46% 61
2023
Q4
$529K Sell
6,422
-410
-6% -$31.2K 0.49% 60
2023
Q3
$525K Hold
6,832
0.52% 61
2023
Q2
$602K Sell
6,832
-50
-0.7% -$4.3K 0.57% 59
2023
Q1
$555K Sell
6,882
-390
-5% -$31.8K 0.55% 63
2022
Q4
$565K Buy
+7,272
New +$589K 0.56% 62

Other funds holding MDT

Applied Capital LLC's MDT Position: Q2 2026 in Review

Applied Capital LLC held its Medtronic (MDT) position steady in Q2 2026 at 5,466 shares worth $428K. The position accounts for 0.17% of the portfolio, ranked #80.

Applied Capital LLC first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $602K in Q2 2023. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Applied Capital LLC held 5,466 shares of Medtronic worth $428K as of Q2 2026.
  • Applied Capital LLC left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.17% of Applied Capital LLC's portfolio in Q2 2026, its #80 holding.
  • Applied Capital LLC first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • Applied Capital LLC's Medtronic position peaked at $602K in Q2 2023.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Applied Capital LLC's 13F filing for Q2 2026, filed 15 Jul 2026.